235 related articles for article (PubMed ID: 24171390)
1. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression.
Levin E; Gupta R; Butler D; Chiang C; Koo JY
J Dermatolog Treat; 2014 Dec; 25(6):501-6. PubMed ID: 24171390
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
4. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse?
Güven A; Gülümser O; Ozgen T
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1173-82. PubMed ID: 18183788
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
[TBL] [Abstract][Full Text] [Related]
6. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.
Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():47-51. PubMed ID: 22512680
[TBL] [Abstract][Full Text] [Related]
7. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
8. Adrenal crisis while on high-dose steroid treatment: what rheumatologist should consider?
Üsküdar Cansu D; Cansu GB; Arik D; Korkmaz C
Rheumatol Int; 2017 Apr; 37(4):657-662. PubMed ID: 27803964
[TBL] [Abstract][Full Text] [Related]
9. A Case of a Post-Operative Addisonian Crisis from HPA Axis Suppression from Inhaled Corticosteroids.
Allen G; Mitchell A; Ramirez M; Holsten S; Shah N
Am Surg; 2019 Sep; 85(9):e483-e484. PubMed ID: 31638547
[No Abstract] [Full Text] [Related]
10. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
Vollenweider P; Waeber G
Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472
[TBL] [Abstract][Full Text] [Related]
11. Maternal use of prednisolone is unlikely to be associated with neonatal adrenal suppression-a single-center study of 16 cases.
de Vetten L; van Stuijvenberg M; Kema IP; Bocca G
Eur J Pediatr; 2017 Aug; 176(8):1131-1136. PubMed ID: 28695270
[TBL] [Abstract][Full Text] [Related]
12. Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary-adrenal axis in post-penetrating keratoplasty patients?
Sandhu SS; Smith JM; Doherty M; James A; Figueiredo FC
Eye (Lond); 2012 May; 26(5):699-702. PubMed ID: 22344184
[TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
Coureau B; Bussières JF; Tremblay S
Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
[TBL] [Abstract][Full Text] [Related]
14. Safety analysis of long-term budesonide nasal irrigations in patients with chronic rhinosinusitis post endoscopic sinus surgery.
Soudry E; Wang J; Vaezeafshar R; Katznelson L; Hwang PH
Int Forum Allergy Rhinol; 2016 Jun; 6(6):568-72. PubMed ID: 26879335
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)--the risk as determined by gold standard adrenal function tests: a systematic review.
Zöllner EW
Pediatr Allergy Immunol; 2007 Sep; 18(6):469-74. PubMed ID: 17680905
[TBL] [Abstract][Full Text] [Related]
16. Is suppression of hypothalamic-pituitary-adrenal axis significant during clinical treatment of phimosis?
Pileggi FO; Martinelli CE; Tazima MF; Daneluzzi JC; Vicente YA
J Urol; 2010 Jun; 183(6):2327-31. PubMed ID: 20400146
[TBL] [Abstract][Full Text] [Related]
17. Oral corticosteroids for asthma exacerbations might be associated with adrenal suppression: Are physicians aware of that?
Barra CB; Fontes MJF; Cintra MTG; Cruz RC; Rocha JAG; Guimarães MCC; Silva IN
Rev Assoc Med Bras (1992); 2017 Oct; 63(10):899-903. PubMed ID: 29267492
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of hypothalamic-pituitary-adrenal axis suppression secondary to intrabursal injection of different glucocorticoids: a pilot study.
Guaraldi F; Gori D; Calderoni P; Castiello E; Pratelli L; Leporati M; Arvat E; Battaglia M
J Endocrinol Invest; 2019 Sep; 42(9):1117-1124. PubMed ID: 30877658
[TBL] [Abstract][Full Text] [Related]
19. The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis.
Habib G; Jabbour A; Salman J; Hakim G; Haddad H
J Clin Anesth; 2013 Dec; 25(8):629-33. PubMed ID: 23988802
[TBL] [Abstract][Full Text] [Related]
20. Prolonged Steroid Dependence in Adult Patients With Glioma.
Mantilla EC; Abramowitz J; Dan TU; Pan E
Anticancer Res; 2020 Apr; 40(4):2059-2064. PubMed ID: 32234897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
